The Society of Gynecological Oncologists issued a statement on July 2 regarding the test OvaSure(TM) .
"After reviewing OvaSure’s materials, it is our opinion that additional research is needed
to validate the test’s effectiveness before offering it to women outside of the context of a
research study conducted with appropriate informed consent under the auspices of an
institutional review board."
For the complete statement click here.